QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Enters Collaboration Agreement with Smart City Company NoTraffic Ltd.

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., has signed a collaboration agreement with NoTraffic Ltd., which has developed a novel and proprietary platform solution that solves today’s traffic challenges while unlocking mobility benefits for traffic agencies. According to the update, the Autonomous Traffic Management Platform enables cities for the first time to intelligently implement traffic policy in a seamless way and operate autonomously in order to maximize traffic flow, reduce congestion, prioritize different types of vehicles, and prevent accidents. Under the agreement, the companies will collaborate to develop and optimize the technological abilities of Eye-Net Mobile’s cellular-based V2X accident prevention solution and NoTraffic’s intelligent traffic management solution. “The technological collaboration between Eye-Net Mobile and NoTraffic has the potential to redefine smart infrastructures and road users’ connectivity,” Eye-Net Mobile COO & Deputy CEO Dror Elbaz said in the news release. “Our cooperation will enhance both products and will enable accident prevention in junctions by sharing real-time information between intelligent traffic lights and connected road users. We believe that the combined solution will be adopted by municipalities and smart cities worldwide seeking to promote smart transportation and reduce the number of accidents in urban environments.”

To view the full press release, visit http://ibn.fm/d9i5c

About Foresight

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement. The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost effective platform and advanced technology. For more information, visit the company’s website at www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces 2019 Annual Results

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced annual results for the year ended December 31, 2019. According to the update, the company reported $7.43 million in revenues from continuing operations compared to $3.83 million for 2018, as well as $125,244 in operating income for the year 2019 compared to an operating loss of ($87,616) in 2018. “In addition to increased revenue growth from our companies, Trxade Group achieved a number of significant milestones around innovation and enhancements in 2019 that add even more value to our role as a strategic provider to independent pharmacies and lower cost healthcare to all consumers,” Trxade Group Chairman and CEO Suren Ajjarapu said in the news release. “We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth.”

To view the full press release, visit http://ibn.fm/5k85q

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes Healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and Same Day or Mail Order Pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

SRAX Inc. (NASDAQ: SRAX) Gives Users Opportunities to Earn Money from Data Without Leaving the Couch

• SRAX recently partnered with charities to allow users to make donations through BIGtoken platform
• BIGtoken allows users to earn from their data while generating reliable data sets that marketers can access
• BIGtoken users estimated at 16 million with revenue potential of $400 million by January 2022

As a quarter of Americans have been told to stay at home for the public’s overall health, a timely opportunity presents itself to Internet-based companies (http://ibn.fm/rxbSO). SRAX Inc. (NASDAQ: SRAX), a marketing and consumer data management technology company, gives users unique opportunities to earn money from their online data through its BIGtoken platform—a unique vehicle to help users earn extra cash while stuck indoors. Besides offering profit solutions for consumers, the company also gives those consumers the option to donate their BIGtoken earnings to charities (http://ibn.fm/6HEfa).

Gifting toward culture and social awareness has always been a standard component of SRAX’s corporate culture. In line with that spirit of connection, the company recently partnered with charities such as The ALS Association, HealthCorps, American Heart Association and Keep a Child Alive to provide BIGtoken users an opportunity to donate what they have earned from sharing their data.

In addition to allowing users to own and earn from their data, the BIGtoken system also generates reliable data sets that marketers can access for a fee. Data obtained by SRAX spans multiple industries, including the automotive, luxury, lifestyle and investor relations spaces, and is often of higher quality than data obtained through general mining techniques because of the permission-based nature of the BIGtoken system.

The BIGtoken platform is an evolution in data management – for users and marketers alike. Millions of users have abandoned some of the most popular social media platforms for various reasons – including concerns about data privacy (http://ibn.fm/QfxBo). BIGtoken presents a solution that offers users clarity, control and compensation for their data.

Based on the platform’s widespread success, SRAX recently announced an initiative to expand through a secured term loan (http://ibn.fm/uCbnu). “This financing will help fuel growth as both BIGtoken.com and SRAXir.com are gaining traction in their goals to be the leaders in their respective data businesses,” CEO Christopher Miglino stated in a news release.

BIGtoken users can earn rewards through the platform by opting into agreements regarding what data is shared and when that data is purchased. They can also earn rewards by answering questions, checking into locations, recruiting new members and more. In addition, BIGtoken users have control over what companies can buy their data and how that data will be used. In short, the entire process creates opportunities for empowered consumers to earn rewards while creating accurate, verified consumer data for targeting.

Current users of BIGtoken are estimated at over 16 million, with a revenue potential projected at $400 million by January 2022. Through several international ventures, the company has launched into new markets including India and Mexico, along with several future multilingual offerings of BIGtoken in Europe.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire Tassili Life Sciences Corp.

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced its entry into a definitive agreement to acquire Tassili Life Sciences Corp. Per the update, the move will expand the Company’s preclinical trial pipeline, as well as its aggregation of broad intellectual property (IP) related to the development of novel psychedelics therapeutics and their delivery systems, targeting multiple pathological psychological diseases. Tassili has partnered with a multidisciplinary team of scientists and physicians at the University of Miami to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries (“mTBI”) and/or post-traumatic stress disorder (“PTSD”). “Mild traumatic brain injury, especially concussion, is a significant cause of morbidity worldwide,” Dr. Michael Hoffer, professor of otolaryngology and neurological surgery at University of Miami’s Miller School of Medicine, stated in the news release. “What many do not realize is that TBI often occurs alongside PTSD. Up to 40% of people impacted by mTBI, a head injury causing a temporary change in mental status or consciousness, or TBI in general, also suffer from PTSD. This combination of mTBI and PTSD is even more common in U.S military members and presents a vast patient population to service and potentially heal with our novel therapeutics under development.”

To view the full press release, visit http://ibn.fm/v4aYW

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a research driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes for indications such as depression and Post Traumatic Stress Disorder (“PTSD”), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php